Vgenomics
PrivateLast Round
Seed
Jan 16, 2024
Total Funding Raised
$350,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Vgenomics is a health tech company that provides an AI-powered cloud platform for the diagnosis of rare genetic diseases and the discovery of therapeutic targets.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Drug Discovery, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vgenomics Comparables
Compare Vgenomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Saphetor | 78% | |
| 3billion, Inc. | 77% | |
| Genomenon Inc. | 77% | |
Vgenomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 16, 2024 |
Vgenomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mumbai Angels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Grew 23% QoQ, from 13 to 16 employees.
- Dec 26, 2025
Grew 30% QoQ, from 10 to 13 employees.
Vgenomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vgenomics's valuation, stock price, and market status.